Have a personal or library account? Click to login
Ex vivo permeability study and in vitro solubility characterization of oral Canagliflozin self-nanomicellizing solid dispersion using Soluplus® as a nanocarrier Cover

Ex vivo permeability study and in vitro solubility characterization of oral Canagliflozin self-nanomicellizing solid dispersion using Soluplus® as a nanocarrier

Acta Marisiensis - Seria Medica
Volume 70 (2024): Issue 2 (June 2024)
By: Nizar Awish Jassem and  Shaimaa Nazar Abd Alhammid  
Open Access
|Jul 2024

Authors

Nizar Awish Jassem

nezar.jassem2100p@copharm.uobaghdad.edu.iq

Department of Pharmaceutics, College of Pharmacy, Al-Ayen Iraqi University, Thi-Qar, Iraq

Shaimaa Nazar Abd Alhammid

Department of Pharmaceutics, College of Pharmacy, University of Baghdad, Baghdad, Iraq
DOI: https://doi.org/10.2478/amma-2024-0011 | Journal eISSN: 2668-7763 | Journal ISSN: 2668-7755
Journal RSS Feed
Language: English
Page range: 42 - 49
Submitted on: Feb 19, 2024
|
Accepted on: May 10, 2024
|
Published on: Jul 3, 2024
Published by: University of Medicine, Pharmacy, Science and Technology of Targu Mures
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
self-nanomicellizing,
bioavailability,
phase solubility,
canagliflozin,
Soluplus
Related subjects:
Medicine,
Clinical medicine,
Clinical medicine, other

© 2024 Nizar Awish Jassem, Shaimaa Nazar Abd Alhammid, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 70 (2024): Issue 2 (June 2024)Next article